Understanding Your Test: A Patient Guide to What to Expect and What Your Results Mean

This test is a diagnostic procedure that helps your healthcare provider gather important information about your health. It may be ordered as part of a routine checkup or to help investigate specific symptoms you have been experiencing.

The 17-Hydroxyprogesterone (17-OHP) test measures the amount of a specific hormone called 17-hydroxyprogesterone in the amniotic fluid that surrounds the baby during pregnancy. This fluid is collected through a procedure called amniocentesis, where a thin needle is used to remove a small sample of amniotic fluid from the uterus for laboratory analysis.

Your doctor may order this test to confirm or rule out a medical condition, monitor an ongoing health problem, or evaluate how well a treatment is working. The results help guide decisions about your care and any further testing that may be needed.

This test is primarily performed to evaluate fetal adrenal gland function and to screen for or diagnose congenital adrenal hyperplasia (CAH). CAH is a genetic condition that affects the adrenal glands' ability to produce certain hormones, particularly cortisol. When a fetus has CAH, the adrenal glands may produce excess androgens (male hormones), which can affect the development of the baby's genitalia, especially in female fetuses. Early detection through this test allows healthcare providers to prepare for appropriate management and treatment after birth.

During the test, a trained member of your care team will walk you through each step and answer your questions. Depending on the type of test, a small sample may be collected or a measurement taken. The procedure is usually quick, and you can typically return to normal activities shortly afterward.

The test requires an amniocentesis procedure. During this procedure, you will lie on an examination table, and an ultrasound will be used to guide a thin needle through your abdomen and into the uterus to collect a small amount of amniotic fluid. The procedure typically takes only a few minutes. You may experience some discomfort or mild cramping during or after the procedure. The collected fluid is then sent to a laboratory where the 17-hydroxyprogesterone level is measured.

Most people tolerate this test very well, and serious complications are rare. You may experience mild, temporary discomfort, such as slight soreness or bruising where a sample was taken. Contact your provider if you notice unusual pain, swelling, bleeding, or signs of infection.

Amniocentesis carries a small risk of complications, including infection, bleeding, leakage of amniotic fluid, injury to the baby or placenta, and in rare cases, miscarriage. The overall risk of miscarriage related to amniocentesis is estimated to be very low (less than 1 in 1,000 to 1 in 500). Your healthcare provider will discuss these risks with you and help you decide if this test is appropriate for your situation.

Your results will be reviewed by your healthcare provider, who will explain what they mean in the context of your overall health. Values outside the typical range do not always indicate a problem, so follow up with your provider to discuss your specific results and whether any next steps are recommended.

Results are reported as the concentration of 17-hydroxyprogesterone in the amniotic fluid. Higher than normal levels may suggest that the fetus has congenital adrenal hyperplasia. However, your healthcare provider will interpret the results in the context of your specific situation, including your family history, pregnancy details, and other test results. If CAH is confirmed, your healthcare team will discuss treatment options and management plans with you.